|
COPYRIGHT 2003 International Medical News Group
Resistance to the cardioprotective effects of aspirin portends a poor outcome for patients with stable cardiovascular disease, said Dr. Patricia A. Gum and her associates at the Cleveland Clinic Foundation.
Of 326 patients on aspirin therapy with histories of coronary stenosis, myocardial infarction, stoke, or invasive revascularization procedures, 17...
Read the full article for free courtesy of your local library.
|